Table 5.

Absenteeism, health care use and medication use

	Intervention group		Control group
		n		n
Absenteeism of school/work (days, previous month)
T1: median (min-max)a	0.00 (0–10)	30	0.00(0–10)	27
T2: median (min-max)b	0.00 (0–20)	25	0.00(0–30)	24
Frequency of health use (whole period)
Consultation Pediatrician/rheumatologist, median (min-max)	3 (0–11)		3.5 (0–28)
Consultation Transition clinical nurse, median (min-max)	1 (0–7)		0 (0–10)
Day-care center, median (min-max)	0 (0–11)		0 (0–8)
Medication use
Non Steroid Anti-rheumatic Drug (NSAID)
T0: n (%)	12(34.3%)	35	9(28.1%)	32
T1: n (%)	15(42.9%)	35	10(31.3%)	32
T2: n (%)	12(34.3%)	35	8(25.0%)	32
Disease Modifying Anti Rheumatic Drug (DMARD)
T0: n (%)	19(54.3%)	35	16(50.0%)	32
T1: n (%)	19(54.3%)	35	15(46.9%)	32
T2: n (%)	16(45.7%)	35	11(34.4%)	32
Biologicals
T0: n (%)	4(11.4%)	35	10(31.3%)	32
T1: n (%)	7(20%)	35	10(31.3%)	32
T2: n (%)	7(20%)	35	8(25%)	32
Medication to reduce pain (paracetamol)
T0: n (%)	6(17.1%)	35	5(15.6%)	32
T1: n (%)	2(5.7%)	35	4(12.5%)	32
T2: n (%)	2(5.7%)	35	5(15.6%)	32

^aMann-Whitney U (Asymp.Sig (2-tailed)) = 313.50 (0.09)

^bMann-Whitney U (Asymp.Sig (2-tailed)) = 284.00 (0.69)